Impact of Metformin on Peripheral Arterial Calcification in Type 1 Diabetes
A phase 3 trial registered on ClinicalTrials.gov. The registry status is active, not recruiting. It plans to enroll 230 participants.
Also called NCT04583462
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose prevention
- Phase
- Phase 3
- Enrolled
- 230 participants
- Registry
-
NCT04583462 -
2018-003121-29
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- France
- Registry status
- Active, not recruiting
Technical summary
Registry record NCT04583462. Randomized; quadruple masking; primary purpose prevention. Start 2021-06-02 (actual); primary completion 2027-09-29 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Impact of Metformin on Peripheral Arterial Calcification in Type 1 Diabetes
- Acronym
- IMPACT-1D
- Condition
- Type 1 Diabetes
- Condition
- Peripheral Arterial Calcification
- Intervention (Drug)
- Metformin
- Intervention (Drug)
- Placebo
- Lead sponsor
- Assistance Publique - Hôpitaux de Paris
Record details
- Record id
cardio:ct-nct04583462- Content hash
685dd3bbfc9a6de1e0b7f6b5be054e69b177ebf7659a5d148527938606c77cbe